Rescue Progesterone Supplementation During Frozen Embryo Transfer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

September 30, 2025

Study Completion Date

June 30, 2026

Conditions
Fertility IssuesEmbryo ImplantationFrozen Embryo Transfer
Interventions
DRUG

Progesterone Effervescent Vaginal Tablet

On the day of Frozen Embryo Transfer (FET), women will have a blood test to determine progesterone levels. Depending on the result of progesterone level, the participant will be assigned to either the Endometrin 100 mg TID dose or the Endometrin 200 mg TID dose

Trial Locations (1)

H4P 2S4

Clinique Ovo, Montreal

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Ferring Pharmaceuticals

INDUSTRY

lead

Clinique Ovo

INDUSTRY